UroGen Pharma(URGN) - 2024 Q1 - Earnings Call Transcript

UroGen Pharma Ltd. (NASDAQ:URGN) Q1 2024 Earnings Conference Call May 13, 2024 10:00 AM ET Company Participants Vincent Perrone - Head of IR Elizabeth Barrett - President & CEO Mark Schoenberg - Chief Medical Officer Don Kim - CFO Jeff Bova - Chief Commercial Officer Conference Call Participants Tara Bancroft - TD Cowen Raghuram Selvaraju - H.C. Wainwright & Co Matt Kaplan - Ladenburg Thalmann Leland Gershell - Oppenheimer Operator Good morning ladies and gentlemen. Thank you for standing by. Welcome to the ...